Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses.

被引：22

作者：

Borghaei, Hossein

Brahmer, Julie R.

Horn, Leora

Ready, Neal

Steins, Martin

Felip, Enriqueta

Paz-Ares, Luis G.

Arrieta, Oscar

Barlesi, Fabrice

Antonia, Scott Joseph

Fayette, Jerome

Rizvi, Naiyer A.

Crino, Lucio

Reck, Martin

Eberhardt, Wilfried Ernst Erich

Hellmann, Matthew David

Desal, Kaushal

Li, Ang

Healey, Diane I.

Spigel, David R.

机构：

[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[4] Duke Univ, Med Ctr, Durham, NC USA

[5] Thoraxklin Heidelberg gGmbh, Heidelberg, Germany

[6] Vall dHebron Univ, Barcelona, Spain

[7] Virgen del Rocio Univ Hosp, Seville, Spain

[8] Inst Nacl Cancerol INCAN, Mexico City, DF, Mexico

[9] Aix Marseille Univ, AP HM, Marseille, France

[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[11] Ctr Leon Berard, Lyon, France

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[13] Osped Perugia, Perugia, Italy

[14] Lungen Clin Grosshansdorf, Airway Res Ctr North ARCN, Grosshansdorf, Germany

[15] Univ Hosp Univ Duisburg Essen, Essen, Germany

[16] Bristol Myers Squibb, Princeton, NJ USA

[17] Sarah Cannon Res Inst, Nashville, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.9025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9025

引用

页数：3